SEEG-guided therapeutic decision-making in drug-resistant epilepsy: retrospective analysis and clinical framework
Acta Neurochirurgica · 12.06.2026 · 168 (1)
DOI: 10.1007/s00701-026-06910-7 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Acta Neurochirurgica, online erschienen am 12.06.2026. Verfasst von Marta Codes und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institut Clínic de Neurociències (ICN), Department of Neurosurgery, Hospital Clínic of Barcelona, University of Barcelona, C/Villarroel 170, 08036, B…. Hauptthemen laut MEDLINE: Clinical Decision-Making, Drug Resistant Epilepsy, Electrocoagulation, Electroencephalography. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitat de Barcelona.
Abstract (Originalsprache)
Background
Stereoelectroencephalography (SEEG) plays a central role in the presurgical evaluation of patients with drug-resistant epilepsy, particularly when noninvasive investigations are inconclusive. Beyond localization of the epileptogenic zone (EZ), its role in guiding therapeutic decision-making remains incompletely defined.
Objective
To evaluate the safety, clinical outcomes, and therapeutic impact of SEEG, including SEEG-guided radiofrequency thermocoagulation (RF-TC), and to develop a structured clinical decision-making framework based on SEEG findings.
Methods
We performed a retrospective analysis of 71 consecutive patients with drug-resistant epilepsy who underwent SEEG monitoring between 2016 and 2025. Clinical, neuroimaging, and electrophysiological data were analyzed, along with procedural variables, complications, and outcomes following RF-TC and resective surgery. SEEG findings were used to stratify patients into distinct therapeutic pathways.
Results
A total of 958 electrodes were implanted (mean 14 ± 4.5 per patient). SEEG confirmed the preimplantation hypothesis in 85% of cases. Based on SEEG findings, 52% of patients were candidates for resective surgery, while 48% were managed conservatively or with neuromodulation strategies. RF-TC was performed in 37 patients (52%), resulting in seizure improvement in 73% at 12 months, although complete seizure freedom was limi. Response to RF-TC influenced subsequent treatment decisions, favoring conservative management in responders and resective surgery in non-responders. Favorable outcomes (Engel I–II) after resective surgery were achieved in 71% of patients at 12 months. Complications were predominantly minor, with a 1% rate of permanent neurological deficit.
Conclusions
SEEG is a safe and effective tool not only for localizing the EZ but also for structuring therapeutic decision-making in drug-resistant epilepsy. SEEG findings enable patient stratification into individualized treatment pathways and support a dynamic, staged approach in which RF-TC may serve as both a therapeutic and decision-modulating tool. This framework highlights the evolving role of SEEG as a central platform in modern epilepsy surgery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institut Clínic de Neurociències (ICN), Department of Neurosurgery, Hospital Clínic of Barcelona, University of Barcelona, C/Villarroel 170, 08036, Barcelona, Spain.
- Institut Clínic de Neurociències (ICN), Department of Neurosurgery, Hospital Clínic of Barcelona, University of Barcelona, C/Villarroel 170, 08036, Barcelona, Spain. alvabego@gmail.com.
- Institut Clínic de Neurociències (ICN), Department of Neurology, Hospital Clínic of Barcelona, University of Barcelona, Barcelona, Spain.
- Institut Clínic de Neurociències (ICN), Department of Anesthesiology and Resuscitation, Hospital Clínic of Barcelona, University of Barcelona, Barcelona, Spain.
Förderung
- Universitat de Barcelona
Zitieren
APA
Codes, M., Bedoya, A., Ferres, A., Mas, A., Carreño, M., Centeno, M., Conde, E., Donaire, A., Olivera, M., Pujol-Ayach, E., Gomez, L., Rumia, J., & Roldan, P. (2026). SEEG-guided therapeutic decision-making in drug-resistant epilepsy: retrospective analysis and clinical framework. Acta Neurochirurgica, 168(1). https://doi.org/10.1007/s00701-026-06910-7
Vancouver
Codes M, Bedoya A, Ferres A, Mas A, Carreño M, Centeno M, et al. SEEG-guided therapeutic decision-making in drug-resistant epilepsy: retrospective analysis and clinical framework. Acta Neurochirurgica. 2026;168(1). doi:10.1007/s00701-026-06910-7
BibTeX
@article{Codes2026,
author = {Codes, Marta and Bedoya, Alvaro and Ferres, Abel and Mas, Albert and Carreño, Mar and Centeno, Maria and Conde, Estefania and Donaire, Antonio and Olivera, Marta and Pujol-Ayach, Eugenia and Gomez, Lorena and Rumia, Jordi and Roldan, Pedro},
title = {SEEG-guided therapeutic decision-making in drug-resistant epilepsy: retrospective analysis and clinical framework},
journal = {Acta Neurochirurgica},
year = {2026},
volume = {168},
number = {1},
doi = {10.1007/s00701-026-06910-7}
}
EUVIMED